GINO BIOW Stock Nasdaq
Equities
DNA
US37611X1000
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 223M | Sales 2025 * | 310M | Capitalization | 1.9B |
---|---|---|---|---|---|
Net income 2024 * | -631M | Net income 2025 * | -534M | EV / Sales 2024 * | 5.47 x |
Net cash position 2024 * | 676M | Net cash position 2025 * | 550M | EV / Sales 2025 * | 4.35 x |
P/E ratio 2024 * |
-2.69
x | P/E ratio 2025 * |
-3.17
x | Employees | 1,218 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 69.13% |
Latest transcript on GINO BIOW
Managers | Title | Age | Since |
---|---|---|---|
Austin Che
FOU | Founder | - | 07-12-31 |
Founder | - | 07-12-31 | |
Reshma Shetty
FOU | Founder | 43 | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
BRD | Director/Board Member | 56 | 21-09-15 |
Arie Belldegrun
BRD | Director/Board Member | 74 | 20-12-31 |
Marijn Dekkers
CHM | Chairman | 65 | 21-09-15 |
1st Jan change | Capi. | |
---|---|---|
+26.28% | 48.09B | |
-3.99% | 40.43B | |
+45.32% | 40.62B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.75% | 11.8B | |
-2.02% | 11.88B |